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Abstract
Background: Kidney transplantation using grafts with multiple vessels (GMVs) is
technically demanding and may be associated with increased risk of complications
or suboptimal graft function. To date, no studies have reported on robot-assisted kidney
transplantation (RAKT) using GMVs.
Objective: To report our experience with RAKT using GMVs from living donors, focusing
on technical feasibility and early postoperative outcomes.
Design, setting, and participants: We reviewed the multi-institutional, prospectively
collected European Association of Urology (EAU) Robotic Urology Section (ERUS)-RAKT
database to select consecutive patients undergoing RAKT from living donors using GMVs
between July 2015 and January 2018. Patients undergoing RAKT using grafts with single
vessels (GSVs) served as controls. In case of GMVs, ex vivo vascular reconstruction
techniques were performed during bench surgery according to the case-specific anatomy.
Intervention: RAKT with regional hypothermia.
Outcome measurements and statistical analysis: Intraoperative outcomes and early
(30 d) postoperative complications and functional results were the main study end-
points. Multivariable logistic regression analysis evaluated potential predictors of
suboptimal renal function at 1 mo.
Results and limitations: Overall, 148 RAKTs were performed during the study period. Of
these, 21/148 (14.2%) used GMVs; in all cases, single arterial and venous anastomoses
could be performed after vascular reconstruction. Median anastomoses and rewarming
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times did not differ significantly between the GMV and GSV groups. Total and cold
ischemia times were significantly higher in the GMV cohort (112 vs 88 min,
p = 0.004 and 50 vs 34 min, p = 0.003, respectively). Overall complication rate and
early functional outcomes were similar among the two groups. No major intra- or
postoperative complications were recorded in the GMV cohort. At multivariable
analysis, use of GMVs was not significantly associated with suboptimal renal function
at 1 mo. Small sample size and short follow-up represent the main study limitations.
Conclusions: RAKT using GMVs from living donors is technically feasible and
achieved favorable perioperative and short-term functional outcomes. Larger studies
with longer follow-up are needed to confirm our findings.
Patient summary: In this study, we evaluated for the first time in literature the
results of RAKT from living donors using kidneys with multiple arteries and veins. We
found that, in experienced centers, RAKT using kidneys with multiple vessels is
feasible and achieves optimal results in terms of postoperative kidney function with a
low number of postoperative complications.
© 2018 European Association of Urology. Published by Elsevier B.V. All rights
reserved.
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Anatomic variations in the renal vasculature are common,
being reported in 25–40% of kidneys [1–3]. Supernumerary
or accessory renal arteries and, to a lesser extent, renal
veins, represent the most common variations [1,3].
Grafts with multiple vessels (GMVs) pose a technical
challenge for kidney transplantation (KT). Several retro-
spective studies using different techniques for vascular
reconstruction [4–8] have demonstrated  feasibility and
safety of KT using GMVs [2,9–16]. However, a recent
review reported increased risks of complications, delayed
graft function (DGF), and lower 1-yr graft survival using
GMVs; however, long-term outcomes were comparable to
those of KT using grafts with single vessels (GSVs)
[9]. Moreover, previous studies have reported a potential
increased rate of ureteral complications for grafts with
accessory lower pole arteries [17,18]; however, this
remains controversial [9].
In 2014, the European Association of Urology (EAU)
Guidelines emphasized that grafts with multiple renal
arteries or anatomical anomalies should not be considered
absolute contraindications for living-donor KT due to the
shortage of renal grafts and living donations [19].
In recent years, robot-assisted KT (RAKT) has been
shown to mirror the principles of open KT while adding
all the advantages of minimally invasive surgery [20,21].
The largest European multicenter study on RAKT has
recently confirmed its feasibility, reproducibility, and safety
when performed by skilled robotic surgeons [22]. Of note,
overall evidence is still premature [23]; in a recent system-
atic review, no significant differences were observed
between open and minimally-invasive KT in terms of
patient and graft survival [24].
Given these promising results, RAKT has now been
adopted at multiple institutions worldwide [2] and its
performance will likely increase in the future.
To date, no studies have reported surgical technique and
outcomes of RAKT using GMVs. Herein we report the EAU
Robotic Urology Section (ERUS) Group experience with
RAKT using GMVs from living donors, focusing on technical
feasibility and perioperative and early functional outcomes.2. Patients and methods
2.1. Patients and dataset
After obtaining the Ethical Committee approval and patients’ informed
consent, data were prospectively collected into the multi-institutional
ERUS-RAKT group database.
For the current study, we retrospectively reviewed the database to
select consecutive patients undergoing RAKT with regional hypothermia
using GMVs from living donors between July 2015 and January 2018 at
the eight European centers included in the ERUS-RAKT group.
We defined GMVs as those with greater than or equal to two renal
arteries and/or greater than or equal to two renal veins. Patients under-
going RAKT using GSVs (one artery and one vein) were used as controls.
Functional outcomes were evaluated with estimated glomerular
filtration rate (eGFR) on postoperative day (POD) 1, 3, 7, and 30,
calculated using the Modified Diet in Renal Disease equation
[25]. DGF was defined as need for dialysis in the first postoperative
week. A detailed overview of the study design is provided in Supple-
mentary Information.
2.2. Preparation of the graft and RAKT technique
All transplant teams at the eight centers included in the ERUS-RAKT
group were highly experienced in living donor nephrectomy, robotic
urologic surgery, and open KT. Moreover, all surgeons involved in this
study followed a standardized modular training program prior to start-
ing their own RAKT experience [22].
All RAKTs performed by each surgeon at each center included in the
study since the beginning of their experience were included in the final
analytical cohort. As such, our study included the learning curve of all
surgeons involved in the RAKT program at each center.
Living donor nephrectomy was performed with a laparoscopic or
robotic approach according to hospital resources and surgeon’s prefer-
ence and skills.
After retrieval, the graft was defatted and perfused with cold storage
solution as in conventional open KT.
In case of GMVs, specific ex vivo vascular reconstruction techniques,
adapted from the open KT experience, have been employed before
introduction of the graft into the recipient (Table 1; Fig. 1). In our series,
the following reconstruction techniques have been employed according
to the case-specific vascular anatomy: (1) conjoined (side-to-side) arte-
rial anastomosis (in a pantaloon fashion), (2) reimplantation (end-to-
side) of a polar artery into the main renal artery, or (3) a combination of
these techniques in case of greater than or equal to three renal arteries
Table 1 – Overview of available surgical techniques for extracorporeal (ex vivo) or in situ vascular reconstruction for open and robot-assisted
kidney transplantation from deceased and living donors using grafts with multiple vessels.a
Technique Open kidney transplantation Robot-assisted kidney transplantation
Deceased donor Living donor Deceased donor Living donor
Grafts with multiple arteries
1. Carrell aortic patch U
[5,9,23]
– Technically feasible
Not described in literature
–
2. Conjoined (side-to-side) arterial anastomosis
(pantaloon fashion)
U
[4,5,7,9]
U
[5,7–11,13,16,17,23]
Technically feasible
Not described in literature
x
11/21 (52%)
3. Re-implantation (end-to-side) of polar artery
into main renal artery
U
[5,7]
U
[5,7,8,10,13,16,23]
Technically feasible
Not described in literature
x
6/21 (28%)
4. Extracorporeal repair with autogenous branched
vascular graft
U
[5,7]
U
[5,7,8]
–
5. Polar artery anastomosis to the inferior
epigastric artery
U
[5]
U
[5,6,8,10,23]
Technically feasible
Not described in literature
U
[21]
6. Separate arterial anastomoses (end-to-side) to
external/common iliac artery
U
[5,7,9]
U
[5,7,9–11,23]
Technically feasible
Not described in literature
Technically feasible
Not described in literature
7. Separate arterial anastomoses (end-to-end) to
hypogastric artery and (end-to-side) external iliac
artery.
U
[5,7,9]
U
[5,7,9,11,23]
– –
8. Arterial anastomoses to branches of hypogastric
artery.
U
[5]
U
[5]
– –
9. Combined vascular reconstruction techniques U
[5]
U
[5]
Technically feasible
Not described in literature
x
1/21 (5%)
[technique no. 2 + no. 3]
10. None (ligation of small accessory artery,
especially if supplying the upper renal pole)
U U
[10,16,23]
Technically feasible
Not described in literature
x
1/21 (5%)
Grafts with multiple veins
1. Conjoined (side-to-side) arterial anastomosis
(pantaloon fashion)
U U Technically feasible
Not described in literature
x
1/21 (5%)
2. Combined vascular reconstruction techniques U U Technically feasible
Not described in literature
x
1/21 (5%)
U = technique described in literature (selected key references are provided); x = technique used in our series.
a The following reconstruction techniques have been employed according to the case-specific vascular anatomy: (1) conjoined (side-to-side) arterial anastomosis
(in a pantaloon fashion) in cases of multiple renal arteries of almost equal caliber; (2) re-implantation (end-to-side) of a polar artery into the main renal artery; or
(3) a combination of these techniques in cases of greater than or equal to three renal arteries and/or complex vascular anatomy. Small accessory renal arteries
supplying the upper pole and with a diameter of <2–3 mm were ligated during bench surgery. In one graft with two renal veins, a conjoined (side-to-side) venous
anastomosis was performed in a pantaloon fashion to create a common venous ostium for subsequent single venous anastomosis to external iliac vein. The second
graft with multiple renal veins (n = 2) in our series was found in a patient with a duplication of the inferior vena cava. In this case, the two renal veins were left
intact on a caval patch and the patch anastomosed to the external iliac vein.
E U R O P E A N U R O L O G Y F O C U S 4 ( 2 0 1 8 ) 17 5 – 1 8 4 177and/or complex vascular anatomy (Table 1). Grafts with one artery and
one vein after ligation of small accessory arteries were not considered as
GMVs.
After vascular reconstruction, the graft kidney was wrapped in a
gauze jacket filled with ice slush and subsequently introduced into the
recipient through the umbilical incision.
At all centers participating in this study, RAKT was performed using a
standardized operative protocol following the principles of the Vattikuti-
Medanta technique [20,21], as previously described [22]. In particular,
even in case of GMVs, end-to-side anastomoses of donor renal vessels to
recipient external iliac vessels were always planned, as recommended
(Fig. 2) [23].
Warm ischemia time (WIT) was defined as the time between renal
circulatory arrest and beginning of cold storage; cold ischemia time (CIT)
was defined as the duration of cold storage, with or without perfusion
with a storage solution before introduction of the graft into the recipient;
rewarming time (RT) was defined as the time between removal of the
kidney from cold storage and start of reperfusion under regional hypo-
thermia (achieved by using ice slush) [22].
2.3. Study endpoints
The main study endpoints included: (1) technical feasibility of RAKT
using GMVs, defined as successful completion of RAKT without the need
of open conversion, (2) intraoperative and early (30 d) postoperativecomplication rate, and (3) early (30 d) functional outcomes. Secondary
endpoints included ischemia times and time to complete vascular
anastomoses.
2.4. Statistical analysis
A detailed overview of statistical analysis for this study is provided in
Supplementary Information.
First, descriptive statistics for the GMVs and GSVs groups were
obtained reporting medians (and interquartile ranges, IQR) for continu-
ous variables, and frequencies and proportions for categorical variables,
as appropriate. The Pearson’s chi-square and Mann-Whitney U tests
were used to compare the distribution of key study variables among
the GMVs and GSVs cohorts.
The same tests were used to compare the distribution of key variables
(including presence of GMVs) among patients with sub-optimal and good
renal function on POD 30 (defined as eGFR below and above the pre-
specified cut-off of 45 ml/min/173 m2).
Then, exploratory multivariable binary logistic regression analysis
was used to test whether specific donor-, recipient-, and surgery-related
factors (including GMVs) were associated with suboptimal renal func-
tion on POD 30.
Statistical analyses were performed using SPSS version 24 (IBM SPSS
Statistics for Mac, Armonk, NY, IBM Corp). All tests were two-sided with a
significance level set at p < 0.05.
Fig. 1 – Intraoperative images showing consecutive phases of extracorporeal (ex vivo) bench vascular reconstruction prior to robot-assisted kidney
transplantation in case of a graft with two separate renal arteries of approximately the same caliber from a living donor. (A–E) After careful
preparation of the two renal arteries, vascular reconstruction was carried out using a conjoined (side-to-side) arterial anastomosis in pantaloon
fashion to create (F–L) a common arterial ostium for subsequent single arterial anastomosis to the external iliac artery (see Fig. 2).
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Overall, 148 RAKTs from living donors were performed
during the study period. Of these, 21 (14.2%) used GMVs.
The graft had two renal arteries and one renal vein in 13/21
(62%) cases, three renal arteries and one renal vein in 6/21Fig. 2 – Intraoperative snapshots during robot-assisted living donor nephrecto
multiple vessels. Surgical technique for bench vascular reconstruction in this c
during robot-assisted living donor nephrectomy. In this case, two separate arte
anastomosis between the single graft vein and external iliac vein during robot
Medanta technique [21]. (E) Creation of a circular arteriotomy by using an aor
graft renal artery (side-to-side arterial anastomosis in a pantaloon fashion bet
principles of the Vattikuti-Medanta technique [21]. (L) Intraoperative snapshot
arterial anastomosis and graft reperfusion.(29%) cases, and one renal artery and two renal veins in 2/21
cases (9%).
Donor-, recipient-, and graft-related characteristics, as
well as the key postoperative and functional outcomes for
the overall cohort and stratified by number of graft vessels
(single vs multiple) are shown in Table 2 and Figure 3.my and robot-assisted kidney transplantation in case of grafts with
ase is shown in Fig. 1. (A) Intraoperative view of renal vascular anatomy
ries of approximately the same caliber were found. (B–D) Venous
ic kidney transplantation following the principles of the Vattikuti-
tic punch. (F–I) Single arterial anastomosis between the reconstructed
ween the two renal arteries) and the external iliac artery following the
 showing the final surgical results after completion of venous and
Table 2 – Descriptive graft-, donor- and recipient-related characteristics, as well as intraoperative, perioperative, and functional outcomes, for the overall cohort (n = 148) and stratified by
number of graft vessels (single vessels and multiple vessels cohorts).a
Number of graft vessels p value
Single vessels
(n = 127)
Multiple vessels
(n = 21)
Overall
(n = 148)
Graft anatomy Ureter, n (single: multiple) 126:1 21:0 147:1 –
Vascular anatomy, n arteries: n veins (n [%]) 1:1 (127 [100]) 2:1 (13 [62])
3:1 (6 [29])
1:2 (2 [9])
1:1 (127 [86])
2:1 (13 [9])
3:1 (6 [4])
1:2 (2 [1])
Living donor Age at surgery (yr) 50 (44–59) 53 (41–64) 50 (43–60) 0.8
Male sex, n (%) 47 (37.0) 8 (42.1) 55 (37.7) 0.7
BMI at surgery (kg/m2) 25.3 (23.0–28.0) 23.9 (22.0–26.9) 25.1 (23.0–27.7) 0.09
Preoperative eGFR (ml/min/1.73 m2) 93 (84–103) 94 (88–101) 93 (85–103) 0.9
Postoperative eGFR (ml/min/1.73 m2) 61 (54–72) 67 (54–78) 62 (54–72) 0.4
Left donor side, n (%) Right 17 (13.4) 3 (14.3) 20 (13.5) 0.9
Left 103 (81.1) 17 (81.0) 120 (81.1)
Missing 7 (5.5) 1 (4.7) 8 (5.4)
Recipient Age at surgery (yr) 45 (33–54) 43 (36–56) 44 (35–54) 0.8
Male sex, n (%) 78 (61.4) 16 (76.2) 94 (63.5) 0.2
BMI at surgery (kg/m2) 25.0 (22.1–28.0) 25.7 (24.0–28.0) 25.1 (22.7–28.0)0.5
Pre-emptive, n (%) 58 (45.7) 12 (57.1) 70 (47.3) 0.3
Dialysis duration (d) 300 (32–370) 365 (30–480) 300 (32–405) 0.9
Charlson comorbidity index, n (%) 2 102 (80.3) 14 (66.7) 116 (78.4) 0.4
3 16 (12.6) 5 (23.8) 21 (14.2)
4 9 (7.1) 2 (9.5) 11 (7.4)
Diabetes mellitus, n (%) 13 (10,2) 2 (9.5) 15 (10.1) 0.9
Previous surgery, n (%) 34 (26.8) 4 (19.0) 38 (25.7) 0.4
Preoperative Hb (mg/dl) 109 (95–124) 108 (96–111) 108 (95–122) 0.5
Preoperative eGFR (ml/min/1.73 m2) 10 (7.9–13) 10.3 (7.6–13.5) 10.0 (7.9–13.0) 0.8
Intraoperative
outcomes
Operative time: incision to closure (min) 240 (215–300) 260 (225–300) 245 (220–300) 0.6
Console time: console start to finish (min) 157 (130–190) 171 (135–190) 160 (130–190) 0.5
Warm ischemia time (min) 2 (2–4) 3 (2–5) 2 (2–4) 0.09
Estimated blood loss (cc) 135 (75–170) 150 (60–170) 140 (70–170) 0.8
Intraoperative complications, n (%) Major 0 (0) 0 (0) 0 (0) 0.3
Bleeding (not requiring blood transfusions) 2 (1.7) 2 (9.5) 4 (2.7)
Conversion to open surgery, n (%) 2 (1.7)
(reason: intraoperative bleeding [n = 1];
difficult graft allocation [n = 1])
1 (4.7)
(reason: intraoperative bleeding)
3 (2.0) 0.2
Postoperative
outcomes
Delta Hb values (mg/dl) POD 1 –6 (–16; 10) 1 (–11; 14) –6 (–16; 10) 0.6
POD 3 –13 (–21; 1) –10 (–16; 7) –12 (–21, 1) 0.7
POD 7 –10 (–21; 5) –7 (–19; 1) –10 (–20; 4) 0.4
POD 30 7 (–11; 26) 8 (1; 23) 7 (–9; 26) 0.8
Postoperative pain (VAS scale) 12 h 5 (3–6) 5 (2–6) 5 (3–6) 0.5
24 h 4 (3–5) 3 (2–5) 4 (3–5) 0.5
36 h 3 (1–3) 3 (3–5) 3 (1–4) 0.9
48 h 2 (1–3) 2 (1–4) 2 (1–3) 0.5
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Table 2 (Continued )
Number of graft vessels p value
Single vessels
(n = 127)
Multiple vessels
(n = 21)
Overall
(n = 148)
Postoperative complications
(Clavien-Dindo classification), n (%)
I 5 (4.1) 1 (4.7) 6 (4.1) 0.4
Bleeding (observation) 1 (0.8) 1 (4.7) 2 (1.4)
Wound infection 1 (0.8) 0 (0) 1 (0.7)
Postoperative ileus 3 (2.5) 0 (0) 3 (2.0)
II 4 (3.3) 1 (4.7) 5 (3.4)
Deep venous thrombosis 1 (0.8) 0 (0) 1 (0.7)
Bleeding requiring transfusions 3 (2.5) 1 (4.7) 4 (2.7)
IIIa 2 (1.7) 0 (0) 2 (1.4)
Nephrostomy tube placement 1 (0.8) 0 (0) 1 (0.7)
Percutaneous drainage of pelvic lymphocele 1 (0.8) 0 (0) 1 (0.7)
IIIb 7 (5.5) 0 (0) 7 (4.7)
Graft nephrectomy
(reason: vascular thrombosis)
3 (2.4) 0 (0) 3 (2.0)
Surgical re-exploration
(reason: bleeding [n = 2]; vascular
complications [n = 1]; ureter complications [n = 1])
4 (3.1) 0 (0) 4 (2.7)
IV–V 0 (0) 0 (0) 0 (0)
JJ stent removal, POD (median, range) 28 (13–110) 29 (15–47) 28 (13–110) 0.9
Length of hospital stay (d) 7 (4–8) 6 (4–8) 7 (4–8) 0.9
90-d hospital re-admission, n (%)
(fever [n = 5]; urinary tract infections [n = 2];
acute kidney injury due to dehydration [n = 1];
drug toxicity [n = 2]; acute rejection [n = 2])
12 (9.4) 3 (14.3) 15 (10.1) 0.6
Functional
outcomes
eGFR (ml/min/1.73 m2) POD 1 20.7 (13.0–25.2) 20.0 (15.9–27.4) 20.2 (13.3–25.6)0.9
POD 3 44.7 (28.0–61.0) 42.5 (31.0–52.8) 44.0 (28.4–57.5)0.6
POD 7 55.0 (44.0–68.7) 45.5 (40.7–62.0) 53.0 (44.0–68.0)0.2
POD 30 60.0 (46.0–75.0)
[n = 119]
49.6 (42.0–67.3)
[n = 18]
58.0 (45.0–75.0)
[n = 137]
0.2
Delta eGFR, POD 3  preoperative (ml/min) 31.0 (18.0–49.0) 30.8 (23.0–41.8) 31.0 (18.0–49.0) 0.8
Delta eGFR, POD 7  preoperative (ml/min) 42.8 (31.0–59.0) 35.4 (31.3–55.0) 42.5 (31.2–58.0) 0.4
Delta eGFR, POD 30  preoperative (ml/min) 47.5 (35.0–64.0)
[n = 119]
41.0 (31.0–67.0)
[n = 18]
44.0 (35.0–64.0)
[n = 137]
0.3
eGFR at 1 yr (ml/min) 58.0 (43.0–69.1)
[n = 62] x
55.0 (48.0–56.0)
[n = 10] x
57.1 (43.2–69.0)
[n = 72] x
0.8
Delayed graft function, n (%) 7 (5.5) 2 (9.5) 9 (6.1) 0.4
Graft survival at 1 mo (%) 97.6 100 97.9 0.8
BMI = body mass index; eGFR = estimated glomerular filtration rate; Hb = hemoglobin; IQR = interquartile range; POD = postoperative day; VAS = visual analog scale; x = patients who were followed-up for >1 yr after robot-
assisted kidney transplantation.
a Values are presented as median (IQR) unless otherwise indicated.
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Fig. 3 – Box-plots showing time for vascular and ureterovesical anastomoses and ischemia times during RAKT for the overall cohort (n = 148) and
stratified by number of graft vessels.
IQR = interquartile range; RAKT = robot-assisted kidney transplantation.
Table 3 – Binary multivariable logistic regression analysis
evaluating donor-, recipient- and surgery-related factors
associated with suboptimal renal function on postoperative day 30
(eGFR <45 ml/min/1.73 m2).
eGFR < 45 ml/min at POD 30
OR (95% CI) p value
Donor age (5 yr-fold) 1.46 (1.06–2.01) 0.02
Donor BMI 0.79 (0.64–1.08) 0.3
Donor preoperative eGFR
(5 ml/min-fold)
0.98 (0.84–1.15) 0.8
Recipient age (5 yr-fold) 1.01 (0.81–1.48) 0.5
Recipient BMI 1.05 (0.89–1.28) 0.5
Graft with multiple vessels
(reference: grafts with single vessels)
3.21 (0.70–14.70) 0.1
Console time 1.01 (0.99–1.02) 0.5
Warm ischemia time 1.06 (0.67–1.67) 0.8
Cold ischemia time 1.03 (0.99–1.02) 0.7
Rewarming time 0.94 (0.86–1.03) 0.1
RAKT number
>20 vs <10 0.17 (0.02–1.25) 0.08
>20 vs 10–20 0.67 (0.15–2.74) 0.5
BMI = body mass index; CI = confidence interval; eGFR = estimated
glomerular filtration rate; OR = odds ratio; POD = postoperative day;
RAKT = robot-assisted kidney transplantation.
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significantly differ between the GMVs and GSVs study groups.
Median times to complete arterial, venous, and ureter-
ovesical anastomoses, as well as the overall RT, did not
significantly differ between RAKTs using GMVs or GSVs
(Fig. 3). Likewise, overall operative time, console time,
and WIT did not differ among the study groups (Table 2).
On the contrary, total ischemia time was significantly higher
for RAKTs using GMVs (112 vs 88 min, p = 0.004), driven by a
significantly longer CIT (50 vs 34 min, p = 0.003; Fig. 3).
Median estimated blood loss was 135 cc and 150 cc for
RAKTs using GSVs and GMVs, respectively (p = 0.8). There
was no difference in delta-Hb values between RAKTs using
GSV or GMV on all PODs (Table 2).
Conversion to open surgery due to intraoperative bleeding
was required in two cases in the GSV cohort and in one case in
the GMV cohort. In all other cases, no major intraoperative
complications were reported in both study groups.
Patients undergoing RAKTs using GMVs did not experi-
ence early (30 d) major (Clavien-Dindo III–V) postoperative
complications (Table 2). Overall postoperative complication
rate, 90-d readmission rate, and length of hospital stay were
similar among the study groups. Hospital readmissions
were due to medical complications including fever, urinary
tract infections, drug toxicity, acute kidney injury, and acute
rejection and were managed conservatively without the
need of any surgical intervention (Table 2).
The eGFR values on POD 1, 3, 7, and 30 showed no
significant differences between the GSVs and GMVs cohorts
(Table 2). Likewise, the rate of DGF did not differ signifi-
cantly between the two groups.
Finally, among the 72/148 (48.6%) patients with follow-
up of >1 yr after RAKT, eGFR did not significantly differ
between RAKTs using GSVs or GMVs (58 vs 55 ml/min/
1.73 m2, respectively, p = 0.8).
Data on functional outcomes 1 mo after RAKT were
available in 137/148 (92.6%) patients. Of 137, 30 (22.0%)
patients had suboptimal renal function on POD 30 (eGFR<45 ml/min/1.73 m2; Supplementary Table 1). At multivar-
iable analysis, only donor age was a significant predictor of
suboptimal renal function on POD 30 (odds ratio [OR] for
each 5-yr increase: 1.46; 95% confidence interval [CI]: 1.06–
2.01; Table 3). Recipient characteristics, use of GMVs, time
to complete vascular anastomoses, and RAKT number were
not associated with this outcome.
4. Discussion
To the best of our knowledge, this is the largest experience
on RAKT using GMVs from living donors. Our study showed
that in this setting, RAKT was technically feasible and
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parable to those of RAKT using grafts with conventional
vascular anatomy.
RAKT has demonstrated to reproduce the principles of
open KT adding all the advantages of minimally invasive
surgery from both patient’s and surgeon’s perspectives
[21,22]. On one hand, KT recipients are ideal candidates
for minimally invasive surgery [2,26]; on the other hand, the
EndoWrist technology, the high-magnification and the
three-dimensional vision provided by the robotic platform,
facilitates performance of precise reconstructive proce-
dures, such as KT, improving surgeon’s ergonomics and
quality of operative field, and reducing technical difficulty
compared with standard laparoscopic techniques [24].
Although data are still premature, RAKT achieved similar
patient and graft survival as open KT [24]. Moreover, sur-
geons who have extensive experience in robotic surgery
appeared to have only minimal or even no learning curve at
all for RAKT [2,27]. These findings suggest that robotic
technology may allow in the future a broader adoption of
minimally invasive KT, especially in high-volume centers.
As such, while RAKT has been adopted at multiple institu-
tions worldwide [2], its use will likely increase in the near
future. In this scenario, given the high rate of anatomic
variations in renal vasculature [1–3], the shortage of living
donations and renal grafts [19], the current conflicting
results of open KT literature on safety of GMVs [9–18],
assessing the outcomes of RAKT using GMVs is a key clinical
and research priority.
Our study provides evidence on this topic for the first
time in literature.
A key finding of our study is that RAKT using GMVs from
living donors is technically feasible. Using appropriate vas-
cular reconstruction techniques (Table 1) and a standard-
ized operative protocol for RAKT [21,22], it was possible to
perform single arterial and venous anastomoses in all cases,
thereby reducing RT and total ischemia time. Accordingly,
time to complete vascular anastomoses, as well as overall
console time and RT, did not significantly differ between
RAKTs using GMVs or GSVs (Table 2; Fig. 3). Notably, the
robotic platform facilitates the performance of vascular
anastomoses, thanks to the articulated instruments,
three-dimensional view, and optimal surgeon ergonomics.
A second finding of our study is that RAKT using GMVs
from living donors appears to be safe, achieving optimal
early (30 d) postoperative outcomes, with no reported
major intra- or postoperative complications. Also, esti-
mated blood loss, length of hospital stay, recipient’s Hb
values, and overall complication rates were comparable
to RAKTs using GSV (Table 2).
A third key finding of our study is that despite longer CIT
and total ischemia time (Fig. 3), probably reflecting a longer
time required for extracorporeal bench vascular reconstruc-
tion, RAKT using GMVs from living donor provided optimal
early functional results that were comparable to those of
RAKT using GSVs (Table 2). However, larger studies with
longer follow-up are needed to confirm these findings.
Despite the larger proportion of GMVs among patients
with suboptimal renal function on POD 30 (defined as eGFR<45 ml/min/1.73 m2; Supplementary Table 1), at multivar-
iable analysis, the only factor that was significantly associ-
ated with reduced renal function on POD 30 in our series
was donor age. Neither donor- or recipient-related charac-
teristics nor surgery-related variables, including case num-
ber (a proxy of learning curve), use of GMVs, and time for
vascular anastomoses, were significantly associated with
suboptimal renal function 1 mo after RAKT (Table 3). Due to
the exploratory nature of our analysis, these findings need
to be confirmed by larger studies in different clinical and
healthcare scenarios.
Despite its novelty, our study is not devoid of limitations.
First, although data were prospectively collected, our
study is retrospective with a limited sample size. Second,
we could evaluate only short-term perioperative and func-
tional outcomes after RAKT. Third, as this series included all
consecutive RAKTs since the beginning of each center’s
experience, an inclusion bias may be present, with more
favorable cases included in the dataset. Since RAKT was
performed at referral high-volume centers by highly trained
transplant teams, our findings might not be generalizable to
all clinical scenarios.
Finally, results of multivariable analysis in our series
should be interpreted as hypothesis-generating rather than
definitive due to the relatively small sample size and the
lack of information on all potential confounders.
These limitations acknowledged, our study represents
a significant first step toward the standardization of
surgical techniques of RAKT in case of GMVs and provides
foundation for further research perspectives. In this
regard, high-quality studies using appropriate designs
[28] are needed to (1) confirm the outcomes of RAKT
using GMVs in larger series with longer follow-up and in
broader clinical scenarios, comparing its outcomes with
those of open KT; (2) define the most appropriate ex vivo
reconstruction techniques in case of GMVs to reduce CIT
and RT during RAKT; (3) outline potential contraindica-
tions for RAKT in case of GMVs, selecting those patients
most likely to experience complications and adverse
functional outcomes; (4) evaluate technical feasibility
and outcomes of RAKT using GMVs from deceased donors;
(5) evaluate novel intra-abdominal cooling system
devices to reduce ischemia-reperfusion injury [29] and
specific biomarkers to monitor graft function after RAKT
[30]; and (6) evaluate the mid-long-term functional out-
comes of RAKT, focusing on predictors of DGF and subop-
timal graft function.
5. Conclusions
This is the largest European multicenter study on RAKT from
living donors using GMVs. In experienced hands, this pro-
cedure was technically feasible and achieved optimal peri-
operative and early functional outcomes that were compa-
rable to those of RAKT using grafts with conventional
vascular anatomy.
Larger studies with longer follow-up are needed to stan-
dardize the surgical technique and confirm the long-term
safety of RAKT using GMVs.
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